Healthcare -
Biotechnology - NASDAQ - US
$ 681.58
-1.68 %
$ 73.7 B
Market Cap
16.85
P/E
REGN - DEPRECIATION & AMORTIZATION
Depreciation & Amortization REGN - Regeneron Pharmaceuticals, Inc.
421 M
LAST VALUE
21.28%
2 YEAR CAGR
23.22%
5 YEAR CAGR
26.16%
10 YEAR CAGR